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Myelin: Keeping nerves well wrapped up
Ueli Suter
The recently determined structure of protein zero, P0,
the most abundant peripheral nerve myelin protein,
provides new insights into the molecular structure of
myelin and potential disease mechanisms in hereditary
peripheral neuropathies.
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The myelin sheath has evolved in vertebrates to achieve
efficient propagation of electrical signals along nerve fibres.
Myelin serves this purpose by providing electrical insula-
tion of large caliber axons, a function that is reflected by its
unique biochemical and structural features. The laminar
myelin consists of the much extended plasma membranes
of glia — Schwann cells in the peripheral nervous system
(PNS) and oligodendrocytes in the central nervous system
(CNS). During development, the glial membrane is
continuously wrapped around the centrally-placed axon,
closely apposing both the extracellular and the intracellular
surfaces of the membrane to form compact myelin. Indivi-
dual glial cells lay down distinct segments of myelin with
the electrical characteristics of high resistance and low
capacitance. The regions devoid of myelin between the
segments are called nodes of Ranvier and contain the
channel proteins that are responsible for the propagation of
action potentials by saltatory conduction.
The analysis of mutations affecting myelination has
revealed a set of proteins that are essential for the devel-
opment and maintenance of myelin structure and function
[1]. Curiously, the myelin protein composition of
mammals differs between the CNS and PNS, particularly
with respect to the most abundant proteins. For example,
proteolipid protein (PLP) is found exclusively in CNS
myelin, whereas protein zero (P0) is restricted to the PNS.
To what extent these proteins may serve similar functions
in the two distinct tissues remains to be determined [2]. 
When the primary amino acid sequence of P0 was revealed
by cDNA cloning, it provided strong hints that this protein
might be one of the key components in accomplishing and
maintaining proper PNS myelin compaction [3]. A model
was proposed suggesting that P0 may be responsible for
maintaining the myelin ‘intraperiod line’ (see Fig. 1) by
adhesive homotypic interactions between the extracellular,
immunoglobulin-like domains of P0 proteins anchored in
apposing membranes. It was further suggested that the
‘major dense line’ (see Fig. 1) might be held together by
electrostatic interactions between the highly basic cyto-
plasmic domain of P0 and the negatively charged head
groups of membrane phospholipids. 
Numerous in vitro studies have subsequently provided
evidence in support of these initial hypotheses and, with
the advent of gene-targeting techniques in mice, conclu-
sive evidence was obtained that P0 is indeed critically
involved in the formation and maintenance of the myelin
ultrastructure [4]. At the same time, genetic linkage analy-
sis in human families revealed associations between muta-
tions in the P0 gene and specific forms of hereditary motor
and sensory neuropathies that are characterized by PNS
myelin deficiencies, adding further support to view that
P0 has a crucial role in the integrity of myelin [5].
Initial attempts to determine how the structure of P0 is
related to its function, and to correlate genotypes and
phenotypes in patients with particular P0 mutations, were
hampered by a lack of detailed structural information
about P0. A major step in overcoming this limitation has
now been taken by Shapiro et al. [6], who have determined
the three-dimensional structure of P0’s unglycosylated
extracellular domain, P0ex, at 1.9 Å resolution. What can
we learn from their results? As predicted by computer-
aided analysis, the P0ex fold is similar to an immunoglob-
ulin variable domain and clearly belongs to the same
structure class. Most interestingly, P0ex oligomerizes
within the crystal and the homotypic interactions
observed may, if they occur in vivo, account at least in
part, for the adhesion between opposing lamellae in
myelin.This hypothesis is consistent with analytical
ultracentrifugation analysis and the spacing between adja-
cent wraps of PNS myelin determined previously by X-ray
diffraction analysis of intact myelin.
In addition to the protein–protein interactions between P0
molecules, analysis of the crystal structure suggests that
the hydrophobic side chains of P0 residues Trp28 and,
less likely, Trp78 may interact directly with the opposing
membrane bilayer [6]. It is conceivable that the two types
of interaction would be cooperative, reinforcing the
formation of a network of adhesive forces that mediate
myelin compaction at the intraperiod line. The combina-
tion of homophilic protein–protein interactions and direct
tryptophan–membrane interactions may also provide the
restraints that account for the regular intermembrane
spacing observed in compact myelin.
With the P0ex structure at high resolution at hand, one
might assume that a detailed structure–function analysis
of this protein would now be straightforward, especially
given the various P0 mutations that have been found to
be associated with dominantly inherited motor and
sensory neuropathies [7]. As this group of diseases is
highly heterogeneous, as reflected in the clinical classifi-
cation into the discrete subtypes Charcot–Marie–Tooth
disease type 1B (CMT1B), Dejerine-Sottas syndrome
(DSS) and congenital hypomyelination (CH), it might be
possible to correlate specific genotypes with the corre-
sponding phenotype. 
Such a structure–function analysis is, indeed, now possi-
ble. For example, deletion of P0 residue Ser34 is
expected, from the structural data, to lead to an unstable
protein, so this mutation is likely to give a null allele, and
patients carrying this mutation accordingly suffer from the
relatively mild disease CMT1B. Replacement of Ser34 by
a cysteine, however, leads to the severe DSS phenotype;
this mutation generates an accessible free thiol group,
which is likely to form disulfide aggregates that may act in
a dominant-negative manner. In support of this interpreta-
tion, substitution of Arg69 by a cysteine residue also
causes DSS, but the equivalent substitution of Tyr53,
which is buried in the hydrophobic core of the protein,
results in CMT1B and is probably a loss-of-function muta-
tion. Furthermore, several other mutations associated with
CMT1B have been suggested to interfere directly with
P0–P0 interactions [6,7]. 
Inferences about disease mechanisms should, however, be
treated with caution, in particular if the proteins affected
are partners in large complexes. The misfolding of a
mutant protein, or faulty interactions between a mutant
protein and its partners, may lead to improper intracellular
traffic, causing a general impairment of cellular physiology
[8]. Such a mechanism may account for the effects of some
PLP mutations in Pelizaeus–Merzbacher disease [9].
Alternatively, mutant P0 molecules, alone or in com-
plexes, may be processed and transported correctly but
exert dominant-negative effects by interfering with the
complex network of wild-type P0 molecules. 
Mutation may also interfere with the interactions between
P0 and other proteins involved in the formation and main-
tenance of myelin, particularly as myelin is likely to
require its components to be present in the correct stoi-
chiometry for proper function [5]. The latter notion is sup-
ported by the finding that in one family with hereditary
peripheral neuropathy, the parents affected by the mild
CMT1B phenotype are heterozygotes for a frame-shift
mutation at the codon for P0 residue Gly74 — which most
likely generates a null allele — whereas the homozygous
children are severely affected by DSS [7]. This view is
also supported by the observed greater severity of the
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Figure 1
Function of P0 in peripheral nerve myelin. The
upper panel shows a schematic longitudinal
section of a myelinated axon with a node of
Ranvier near the center. Neurofilaments are
represented by branched blue lines within the
axoplasm. The lower left panel shows the
regular structure of compact myelin observed
in the electron microscope, divided into the
alternating intraperiod lines (IPL; extracellular)
and major dense lines (MDL; intracellular).
The lower right panel shows the putative
arrangement of P0 tetramers (red) into an
adhesive network within the IPL. The potential
interaction of the positively charged
intracellular domain of P0 (+) with negatively
charged phospholipids (–) as part of the
adhesive forces in the MDL is indicated.
Ellipsoids represent P0ex tetramers; large
rectangles represent the highly basic
intracellular domains of P0; and small
rectangles represent potential direct
interactions of tryptophan residues with the











– – – –
mutant phenotype in mice that are homozygous for a
targeted mutation of the P0 gene, relative to mice hetero-
zygous for the same mutation [4].
Despite the recent progress in elucidating the structure
and function of P0, a number of important questions
remain open. For example, what role does P0’s carbohy-
drate moiety play? The finding that the carbohydrate
attachment site is mutated in one case of CMT1B [7] sug-
gests it may be important. Does P0 engage in heterotypic
interactions with other myelin proteins, and if so which
ones? Is the expression of P0 in Schwann cells long before
the start of myelination biologically relevant? The appar-
ent delay in myelination in P0 mutant mice [4] suggests
P0 plays a role in the initiation of myelination — but what
role, precisely? How does the intracellular domain of P0
contribute to its clustering and adhesive properties, and
interaction with the cytoskeleton [10]? And, in this
context, is it just by chance that the only known case of
CH is due to a nonsense mutation in the intracellular
domain of P0 [7]? Following up on these and related ques-
tions should not only shed more light on the multiple roles
of P0 in myelination, but may also help clarify disease
mechanisms in hereditary neuropathies, with the ultimate
goal of finding suitable therapies for the affected patients.
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